Show simple item record

dc.contributor.authorHarries, A D
dc.contributor.authorKumar, A M
dc.contributor.authorSatyanarayana, S
dc.contributor.authorLin, Y
dc.contributor.authorZachariah, R
dc.contributor.authorLönnroth, K
dc.contributor.authorKapur, A
dc.date.accessioned2016-03-12T10:25:21Zen
dc.date.available2016-03-12T10:25:21Zen
dc.date.issued2016-03-01en
dc.identifier.citationAddressing diabetes mellitus as part of the strategy for ending TB. 2016, 110 (3):173-9 Trans. R. Soc. Trop. Med. Hyg.en
dc.identifier.issn1878-3503en
dc.identifier.pmid26884497en
dc.identifier.doi10.1093/trstmh/trv111en
dc.identifier.urihttp://hdl.handle.net/10144/601260en
dc.description.abstractAs we enter the new era of Sustainable Development Goals, the international community has committed to ending the TB epidemic by 2030 through implementation of an ambitious strategy to reduce TB-incidence and TB-related mortality and avoiding catastrophic costs for TB-affected families. Diabetes mellitus (DM) triples the risk of TB and increases the probability of adverse TB treatment outcomes such as failure, death and recurrent TB. The rapidly escalating global epidemic of DM means that DM needs to be addressed if TB-related milestones and targets are to be achieved. WHO and the International Union Against Tuberculosis and Lung Disease's Collaborative Framework for Care and Control of Tuberculosis and Diabetes, launched in 2011, provides a template to guide policy makers and implementers to combat the epidemics of both diseases. However, more evidence is required to answer important questions about bi-directional screening, optimal ways of delivering treatment, integration of DM and TB services, and infection control. This should in turn contribute to better and earlier TB case detection, and improved TB treatment outcomes and prevention. DM and TB collaborative care can also help guide the development of a more effective and integrated public health approach for managing non-communicable diseases.
dc.language.isoenen
dc.publisherOxford University Pressen
dc.rightsPublished by Elsevier Archived on this site with the kind permission of Elsevier Ltd. ([url]http://www.sciencedirect.com/science/journal/00359203[/url]) and the Royal Society of Tropical Medicine and Hygiene ([url]http://www.rstmh.org/transactions.asp[/url])en
dc.titleAddressing Diabetes Mellitus as Part of the Strategy for Ending TBen
dc.typeArticleen
dc.identifier.journalTransactions of the Royal Society of Tropical Medicine and Hygieneen
refterms.dateFOA2019-03-04T12:40:51Z
html.description.abstractAs we enter the new era of Sustainable Development Goals, the international community has committed to ending the TB epidemic by 2030 through implementation of an ambitious strategy to reduce TB-incidence and TB-related mortality and avoiding catastrophic costs for TB-affected families. Diabetes mellitus (DM) triples the risk of TB and increases the probability of adverse TB treatment outcomes such as failure, death and recurrent TB. The rapidly escalating global epidemic of DM means that DM needs to be addressed if TB-related milestones and targets are to be achieved. WHO and the International Union Against Tuberculosis and Lung Disease's Collaborative Framework for Care and Control of Tuberculosis and Diabetes, launched in 2011, provides a template to guide policy makers and implementers to combat the epidemics of both diseases. However, more evidence is required to answer important questions about bi-directional screening, optimal ways of delivering treatment, integration of DM and TB services, and infection control. This should in turn contribute to better and earlier TB case detection, and improved TB treatment outcomes and prevention. DM and TB collaborative care can also help guide the development of a more effective and integrated public health approach for managing non-communicable diseases.


Files in this item

Thumbnail
Name:
Harries et al - 2016 - Addressing ...
Size:
191.0Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record